Anticorps anti-CTLA-4

Author： Robert Caroline   Mateus Christine  

Publisher： Edp Sciences

E-ISSN： 1958-5381|27|10|850-858

ISSN： 0767-0974

Source： Médecine/sciences, Vol.27, Iss.10, 2011-10, pp. : 850-858

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systematic review: colitis associated with anti‐CTLA‐4 therapy

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 4, 2015-08 ,pp. : 406-417

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: anti‐CTLA‐4‐associated colitis and inflammatory bowel disease pathogenesis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 8, 2015-10 ,pp. : 1031-1032

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: anti‐CTLA‐4‐associated colitis and inflammatory bowel disease pathogenesis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 8, 2015-10 ,pp. : 1031-1032

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of PD‐1−/− mice with amodiaquine and anti‐CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients

By  

HEPATOLOGY, Vol. 61, Iss. 4, 2015-04 ,pp. : 1332-1342

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: anti‐CTLA‐4‐associated colitis and inflammatory bowel disease pathogenesis – authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 8, 2015-10 ,pp. : 1032-1033

John Wiley & Sons Inc

Access to resources Recommend Favorite